NORTHWEST BIOTHERAPEUTICS INC (NWBO) Net income 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$60.2MFY2025 · since FY2016: -$80.2M → -$60.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$60.2M | +28.2% |
| FY2024 | -$83.8M | -33.8% |
| FY2023 | -$62.6M | +40.4% |
| FY2022 | -$105.0M | -158.6% |
| FY2021 | $179.1M | +133.8% |
| FY2020 | -$529.8M | -2445.7% |
| FY2019 | -$20.8M | +41.9% |
| FY2018 | -$35.8M | +51.1% |
| FY2017 | -$73.1M | +8.8% |
| FY2016 | -$80.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NWBO financial trends
NWBO RevenueNWBO Net marginNWBO Gross profitNWBO Gross marginNWBO Operating incomeNWBO Operating marginNWBO Operating cash flowNWBO Free cash flowNWBO Capital expendituresNWBO Return on equityNWBO Stock buybacksNWBO Dividends paidNWBO Total assetsNWBO Total liabilitiesNWBO Shareholders’ equityNWBO overview →